These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5719704)

  • 1. [Fusidic acid evaluation using Bacillus licheniformis].
    Fernandez F; Piña M
    Microbiol Esp; 1968; 21(1):39-44. PubMed ID: 5719704
    [No Abstract]   [Full Text] [Related]  

  • 2. [A spectrophotometric method of analysis of fusidic acid].
    Satarova DE; Korchagin VB; Stepushkina VV; Makarova RA
    Antibiot Khimioter; 1989 Aug; 34(8):566-9. PubMed ID: 2589895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of the admixtures in fusidic acid and its salts].
    Suchkova GS; Lokshin GB; Kliuev NA; Kuzovkov AD
    Antibiotiki; 1981 Jan; 26(1):16-9. PubMed ID: 7212677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Semiquantitative method of evaluating admixtures in fusidic acid and its sodium salt].
    Moroz NS; Lukina TV; Suchkova GS; Lokshin GV; Korchagin VB
    Antibiotiki; 1981 Feb; 26(2):89-92. PubMed ID: 7194016
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fusidic acid concentrations in chronically inflamed tissue. Studies of chronic posttraumatic osteomyelitis].
    Hierholzer G; Knothe H; Rehn J; Koch F
    Arzneimittelforschung; 1966 Nov; 16(11):1549-52. PubMed ID: 6014976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agar diffusion method for a determination of fucidin in body fluids and tissues].
    Koroleva VG
    Antibiotiki; 1971; 16(8):727-9. PubMed ID: 5003151
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of co-immobilization of Trichosporon cutaneum and Bacillus licheniformis for a BOD sensor.
    Suriyawattanakul L; Surareungchai W; Sritongkam P; Tanticharoen M; Kirtikara K
    Appl Microbiol Biotechnol; 2002 Jun; 59(1):40-4. PubMed ID: 12073129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution properties of taurine and glycine conjugates of fusidic acid and its derivatives.
    Carey MC; Small DM
    Biochim Biophys Acta; 1973 Apr; 306(1):51-7. PubMed ID: 4703575
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of fusidic acid and sodium fusidate in pharmaceutical dosage forms by first-derivative ultraviolet spectrophotometry.
    Hassan SM; Amer SM; Amer MM
    Analyst; 1987 Oct; 112(10):1459-61. PubMed ID: 3434825
    [No Abstract]   [Full Text] [Related]  

  • 11. Spectrophotometric determination of fusidic acid and sodium fusidate in dosage forms.
    Vladimirov S; Fiser Z; Agbaba D; Zivanov-Stakic D
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):675-8. PubMed ID: 9696587
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative evaluation of three detectors in the HPLC analysis of sodium fusidate.
    Gatti R; Gotti R; Bonazzi D; Cavrini V
    Farmaco; 1996 Feb; 51(2):115-9. PubMed ID: 8857206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-identification of the halotolerant, biosurfactant-producing Bacillus licheniformis strain JF-2 as Bacillus mojavensis strain JF-2.
    Folmsbee M; Duncan K; Han SO; Nagle D; Jennings E; McInerney M
    Syst Appl Microbiol; 2006 Dec; 29(8):645-9. PubMed ID: 16488097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological oxidation of fusidic acid.
    Dvonch W; Greenspan G; Alburn HE
    Experientia; 1966 Aug; 22(8):517. PubMed ID: 5968623
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of an asporogenic Bacillus licheniformis for the production of keratinase.
    Wang JJ; Greenhut WB; Shih JC
    J Appl Microbiol; 2005; 98(3):761-7. PubMed ID: 15715880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced production of poly (gamma-glutamic acid) from Bacillus licheniformis NCIM 2324 by using metabolic precursors.
    Bajaj IB; Singhal RS
    Appl Biochem Biotechnol; 2009 Oct; 159(1):133-41. PubMed ID: 19005621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of small cytoplasmic RNA confers fusidic-acid resistance on Bacillus subtilis.
    Shibata T; Nakamura Y; Nakamura K; Yamane K
    Biochem Biophys Res Commun; 1995 May; 210(2):317-23. PubMed ID: 7538759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphate-starvation response of Bacillus licheniformis.
    Hoi le T; Voigt B; Jürgen B; Ehrenreich A; Gottschalk G; Evers S; Feesche J; Maurer KH; Hecker M; Schweder T
    Proteomics; 2006 Jun; 6(12):3582-601. PubMed ID: 16705752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with fucidin in the treatment of osteomyelitis.
    Pahle JA
    Acta Orthop Scand; 1969; 40(5):675. PubMed ID: 5378137
    [No Abstract]   [Full Text] [Related]  

  • 20. Production and characterization of a low-molecular-weight bacteriocin from Bacillus licheniformis MKU3.
    Kayalvizhi N; Gunasekaran P
    Lett Appl Microbiol; 2008 Dec; 47(6):600-7. PubMed ID: 19120933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.